Skip to content

Comparison of paracetamol versus ketorolac on decreasing of low back pain: clinical trial

Comparison of paracetamol versus ketorolac on decreasing of low back pain: clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201404127327N1
Enrollment
100
Registered
2015-02-01
Start date
2014-06-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back paine. Dorsalgia, unspecified

Interventions

Intervention 1: Intervention group: After confirming diagnosis, 1 gram paracetamol will be soluted in 100 cc normal saline and will be infused in 10 minute. Drug name: Intravenous Paracetamol Chemica
Treatment - Drugs
Intervention group: After confirming diagnosis, 1 gram paracetamol will be soluted in 100 cc normal saline and will be infused in 10 minute. Drug name: Intravenous Paracetamol Chemical compound: Ac
Control group: one ampule of ketorolac in order to stimulation will be soluted in 100 cc normal saline and will be infused in 10 minutes. Drug name: Ketorolac Chemical compound: Ketorolac Dose: one

Sponsors

Student Research Commitee, Tabriz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients between 18 up to 65 years old with chief complaint of low back pain. Exclusion criteria: Patients who have contraindication for use of NSAID; use of opioid in last six hours; patients with red flag symptoms such as neurological abnormalities or fever; patients with suggestive signs for discopathy in MRI.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain severity. Timepoint: In intrance, after 10, 20, 30 minute and 24 hour later. Method of measurement: Visual Analoge score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Samad Shams Vahdati

Tabriz University of Medical sciences

shams@tbzmed.ac; irsshamsv@yahoo.com+98 41 1335 2078

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026